<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Choice of antihypertensive monotherapy does not predict outcome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Choice of antihypertensive monotherapy does not predict outcome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Choice of antihypertensive monotherapy does not predict outcome</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">In the ALLHAT trial, cumulative event rates for the primary outcome (fatal coronary heart disease or nonfatal myocardial infarction) according to primary treatment with chlorthalidone, amlodipine, or lisinopril. Compared to chlorthalidone, there was no significant difference with amlodipine (relative risk 0.98) or lisinopril (relative risk 0.99 percent) at a mean of 4.9 years.</div><div class="graphic_reference">Data from: The ALLHAT Officers, JAMA 2002; 288:2981.</div><div id="graphicVersion">Graphic 82432 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
